Ribometrix
Ribometrix is a biotechnology company pioneering a completely new class of small molecule therapeutics that directly target and modulate the function of RNA to treat human diseases. Ribometrix leverages its world-leading expertise in three-dimensional structural analysis of RNA to drive its discovery platform for the identification of novel small molecules that modulate the function of RNA and proteins associated with human disease. Ribometrix has established collaborations with Genentech, a member of the Roche Group, and Vertex Pharmaceuticals, which leverages Ribometrix's discovery platform. Ribometrix is headquartered in Durham, North Carolina.
Last updated on